Health ❯ Vaccines ❯ mRNA Vaccines

COVID-19 Vaccines

Safety Concerns Public Health Policy Vaccine Development Vaccine Efficacy Effectiveness Efficacy and Safety FDA Approval Safety and Effectiveness US Health Policy Moderna Funding Delivery Methods DNA Integration Safety and Efficacy Contaminants Funding Cuts Development and Research BA.3.2 Vaccine Efficacy Safety Public Health Implications Research and Development

6 ARTICLES

last mo.

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

The authors say rare myocarditis after vaccination is lower than the risk from COVID, urging continued monitoring, clearer public communication, investment to expand manufacturing and wider global access.

9 ARTICLES

last yr.

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

12 ARTICLES

last yr.

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

28 ARTICLES

last yr.

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

3 ARTICLES

last yr.

Trump Administration Cuts Moderna Funding and Disbands mRNA Vaccine Panel